Tarsons Products
Financials
Estimates*
INR | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Revenues | 1.7b | 2.3b | 3.0b | 2.8b | 3.0b | 3.8b | 4.4b |
% growth | - | 30 % | 31 % | (5 %) | 5 % | 30 % | 15 % |
EBITDA | 731m | 1.1b | 1.6b | 1.4b | 1.1b | 1.1b | 1.5b |
% EBITDA margin | 42 % | 48 % | 54 % | 50 % | 38 % | 30 % | 33 % |
Profit | 405m | 689m | 1.0b | 807m | 426m | 477m | 666m |
% profit margin | 23 % | 30 % | 34 % | 28 % | 14 % | 12 % | 15 % |
EV / revenue | - | - | 12.3x | 10.2x | 7.9x | 7.0x | 6.0x |
EV / EBITDA | - | - | 22.9x | 20.3x | 21.1x | 23.5x | 17.9x |
Date | Investors | Amount | Round |
---|---|---|---|
* | $41.1m | Late VC | |
* | N/A | N/A | IPO |
Total Funding | €37.4m |
Recent News about Tarsons Products
EditTarsons is a leading manufacturer and supplier of high-quality plastic labware and instruments, catering to the healthcare, pharmaceutical, biotech, food, and environmental sectors globally. The company specializes in producing disposable plastic labware, centrifuge ware, cryo labware, liquid handling systems, and various laboratory instruments. Tarsons leverages advanced technologies such as quality injection moulding and robotics in manufacturing to ensure the highest standards of product quality and reliability. The business model focuses on innovation, customer satisfaction, and trust-based relationships, which are pivotal in maintaining a loyal customer base and driving revenue. Tarsons generates income through the sale of its comprehensive range of laboratory consumables and instruments, which are engineered to meet the specific needs of modern laboratories. The company's commitment to research and development ensures continuous improvement and introduction of revolutionary scientific products.
Keywords: plastic labware, healthcare, biotech, environmental, innovation, research, quality, robotics, customer satisfaction, laboratory instruments.